Human Food Chemical And Drug Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 6 Year, 11 Days
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 71.40%
- Profit Growth 112.30%
- Ebitda 176.17%
- Net Worth 1.52%
- Total Assets 1.74%
About Human Food Chemical And Drug Pharmaceuticals
Human Food Chemical And Drug Pharmaceuticals Private Limited (HFCADPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2019 (Six years 11 days old ). Its registered office is in Ghazipur, Uttar Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Pandey and Kanhaiya Jha serve as directors at the Company.
Company Details
- Location
Ghazipur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999UP2019PTC113562
- Company No.
113562
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2019
- Date of AGM
10 Oct 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Human Food Chemical And Drug Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Pandey  | Director | 12-Feb-2019 | Current |
| Kanhaiya Jha | Additional Director | 21-Jan-2020 | Current |
Financial Performance of Human Food Chemical And Drug Pharmaceuticals.
Human Food Chemical And Drug Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 71.4% increase. The company also saw a substantial improvement in profitability, with a 112.3% increase in profit. The company's net worth moved up by a moderate rise of 1.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Human Food Chemical And Drug Pharmaceuticals?
Unlock access to Human Food Chemical And Drug Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Human Food Chemical And Drug Pharmaceuticals?
Unlock and access historical data on people associated with Human Food Chemical And Drug Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Human Food Chemical And Drug Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Human Food Chemical And Drug Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
